Andreas Raabe News Today

Adragos Pharma is a contract development and manufacturing organization (CDMO) that provides development and manufacturing services for drug products. It concentrates on small molecule dosage forms including sterile and non-sterile liquids, solids, and semi-solids products.

BERN, SWITZERLAND / ACCESSWIRE / January 4, 2024 / LEM Surgical AG, an innovative surgical robotics company headquartered in Bern, Switzerland, announces the successful completion of its Series B funding, securing CHF 22 million. The round, which was strongly oversubscribed, reflects the strong investors' confidence...

LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready ...

Definitive agreements with Fresenius Kabi have been signed by Prange Group and its affiliate Adragos Pharma for its sterile pharmaceutical production site in Halden, Norway.

The Fresenius Kabi manufacturing site is in Halden, Norway.

Adragos Pharma - Munich / London / Athens - - Adragos on a growth path: Three locations in Europe and ...✚ Read more

Adragos on a growth path: Three locations in Europe and five globallyAcquisition strengthens Adragos end-to-end integrated pharmaceutical product...

NEWS AKTUELL // Munich / London / Athens, March 20th, 2023 - Munich-based pharmaceutical contract...

Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment Agreement includes further product development activities for Clinigen Limited Lamda spurs further growth for Adragos as its 3rd site in Europe, and 5th globally Munich / London / Athens, March 20th, 2023 - Munich-based pharmaceutical contract development organization (CDMO) Adragos Pharma GmbH has signed a definitive agreement with global pharmaceutical services company ...

Adragos Pharma now third largest pure-play CDMO in the Japanese market Long-term agreement with Sanofi secures local healthcare supply Munich / Paris / Tokyo, March 02, 2023 – Munich-based pharmaceutical contract manufacturer (CDMO) Adragos Pharma GmbH successfully completed the acquisition of one of Japan's leading pharmaceutical manufacturing facilities from Sanofi K.K. The transaction makes Adragos Pharma the third largest pure-play contract manufacturer in Japan, one of its three core...